CTLA4 and cancer: Anti-programmed cell death protein-1 (Anti-PD-1)/Anti-programmed cell death ligand-1 (Anti-PD-L1) or Anti-cytotoxic T lymphocyte associated protein 4 (Anti-CTLA-4) antibodies are currently attractive anti-cancer immune checkpoints blockers (ICB).